期刊文献+

T2 WI、DWI和动态增强MRI联合应用对前列腺中央腺体癌诊断的价值 被引量:16

Preliminary study of combining T2-weighted imaging, diffusion weighted imaging and dynamic contrast enhanced-magnetic resonance imaging for diagnosing prostatic central gland cancer
原文传递
导出
摘要 目的:以病理结果为金标准,探讨T2 WI、DWI和DCE-MRI三种技术单独及联合应用对前列腺中央腺体癌( CGPCa)的诊断价值。方法回顾性分析宁夏医科大学总医院2009年1月至2012年12月经病理证实的42例CGPCa 和42例良性前列腺增生症( BPH )患者的T2 WI、DWI和DCE-MRI资料,通过诊断试验方法计算每种技术单独及联合应用诊断CGPCa的敏感性、特异性,根据kappa值判断MRI诊断结果和病理结果的一致性,采用ROC曲线下面积(AZ)比较不同方法的诊断效能。结果 T2 WI 诊断 CGPCa 的敏感性、特异性、AZ 和 kappa 值分别为66.7%、76.2%、0.714和0.429;DWI为78.6%、81.0%、0.798和0.595;DCE-MRI为83.3%、61.9%、0.726和0.452。 DWI诊断CGPCa的AZ优于T2WI,差异有统计学意义(P<0.05),与DCE-MRI相比差异无统计学意义(P>0.05)。 T2 WI、DWI 和 DCE-MRI 三者联合诊断 CGPCa 的敏感性、特异性、AZ 和 kappa 值分别为90.5%、88.1%、0.893和0.786,诊断效能( AZ )均优于每种技术的单独应用,差异均有统计学意义(均P<0.05)。结论 DWI独立诊断CGPCa效能优于T2 WI;将T2 WI、DWI和DCE-MRI三者联合应用能显著提高诊断效能,且诊断结果与病理分析一致性较好。 Objective To explore the value of combining T2-weighted imaging ( T2 WI ) , diffusion weighted imaging ( DWI ) and dynamic contrast enhanced-magnetic resonance imaging ( DCE-MRI ) for qualitatively diagnosing central gland prostate cancer (CGPCa) as a gold standard with pathologic findings.Methods A total of 42 cases with CGPCa and 42 cases with benign prostate hyperplasia ( BPH) proved by pathology were followed up with T2 WI, DWI and DCE-MRI examinations retrospectively.The diagnosis sensitivity and specificity by T2 WI, DWI, DCE-MRI alone and combination were calculated respectively.And the consistency of MRI diagnosis and pathological results was judged by Kappa value and the diagnostic value of each method evaluated by Az of receiver operating characteristic curve.Results While using T2 WI alone, the diagnostic sensitivity, specificity, Az and Kappa value was 66.7%, 76.2%, 0.714 and 0.429;DWI 78.6%, 81.0%, 0.798 and 0.595;DCE-MRI 83.3%, 61.9%, 0.726 and 0.452, Az between DWI and T2 WI was statistically significant ( P〈0.05 ) while DCE-MRI insignificant ( P〉0.05 ).When combining T2WI +DWI +DCE-MRI, the diagnostic sensitivity, specificity, Az and Kappa value was 90.5%, 88.1%, 0.893 and 0.786, Az between T2 WI+DWI+DCE-MRI and T2 WI, DWI and DCE-MRI was statistically significant respectively ( all P〈0.05 ).Conclusion DWI is better than T2 WI for diagnosing CGPCa.Combining T2 WI+DWI+DCE-MRI can obviously improve the diagnostic accuracy of CGPCa.And it has excellent consistency with pathological analysis.
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第31期2448-2451,共4页 National Medical Journal of China
基金 宁夏自然科学基金(NZ09110、NZ1234)
关键词 前列腺肿瘤 磁共振成像 弥散 造影剂 Prostatic neoplasms Diffusion magnetic resonance imaging Contrast media
  • 相关文献

参考文献12

  • 1Baccos A, Schiavina R, Zukerman Z, et al. Accuracy ofendorectal Magnetic Resonance Imaging ( MRI) and DynamicContrast Enhanced-MRI ( DCE-MRI) in the preoperative localstaging of prostate cancerf J]. Urologia,2012,79 : 116-122.
  • 2Nagarajan R, Margolis D,Raman S, et al. MR spectroscopicimaging and diffusion-weighted imaging of prostate cancer withGleason scores[ J]. J Magn Reson Imaging,2012,36 :697-703.
  • 3Hoeks CM, Barentsz JO, Hambrock T, et al. Prostate cancer:multiparametric MR imaging for detection,localization, andstaging[ J]. Radiology ,2011,261 :46-66.
  • 4王进有,沈益君,刘小航,张海梁,叶定伟,姚旭东,张世林,戴波,朱耀,周良平.弥散加权磁共振联合经直肠超声定位的前列腺穿刺活检的初步运用[J].中华医学杂志,2012,92(8):512-515. 被引量:14
  • 5李鹏,杨文君,陈志强,杜奕,李燕,郭玉林,王燕蓉,王晓东,侯登华,蔡磊.前列腺癌动态对比增强MRI与扩散加权成像的相关性[J].中国医学影像技术,2013,29(2):264-268. 被引量:28
  • 6Barentsz JO,Richenberg J,Clements R, et al. ESUR prostate MRguidelines 2012[ J]. Eur Radiol,2012,22:746-757.
  • 7Iwazawa J, Mitani T, Sassa S, et al. Prostate cancer detectionwith MRI: is dynamic contrast-enhanced imaging necessary inaddition to diffusion-weighted imaging? [ J]. Diagn Interv Radiol,2011,17:243-248.
  • 8Haider MA, van der Kwast TH,Tanguay J, et al. Combined T2-weighted and diffusion-weighted MRI for localization of prostatecancer[ J]. AJR Am J Roentgenol ,2007,189:323-328.
  • 9Hricak H, Choyke PL, Eberhardt SC, et al. Imaging prostatecancer : a multidisciplinary perspective [ J ]. Radiology,2007,243:28-53.
  • 10Kitajima K, Kaji Y, Fukabori Y,et al. Prostate cancer detectionwith 3T MRI: Comparison of diffusion-weighted imaging anddynamic contrast-enhanced MRI in combination with T2-weightedimaging[ J]. J Magn Reson Imaging, 2010,31 :625-631.

二级参考文献30

  • 1王霄英,丁建平,周良平,李飞宇,范晓颖,王继琛,蒋学祥.前列腺癌的MR扩散成像初步研究[J].中华放射学杂志,2005,39(11):1207-1209. 被引量:68
  • 2叶定伟.前列腺癌的流行病学和中国的发病趋势[J].中华外科杂志,2006,44(6):362-364. 被引量:168
  • 3Catalona WJ,Richie JP,Ahmann FR,et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer:results of a multicenter clinical trial of 6,630 men.J Urol,1994,151:1283-1290.
  • 4Rietbergen JB,Kranse R,Hoedemaeker RF,et al.Comparison of prostate-specific antigen corrected for total prostate volume and transition zone volume in a population-based screening study.Urology,1998,52:237-246.
  • 5Hosseinzadeh K, Schwarz SD. Endorectal diffusion weighted imaging in prostate cancer to differentiate malignant and benign peripheral zone tissue. J Magn Reson Imaging,2004,20:654-661.
  • 6Pickles MD,Gibbs P,Sreenivas M,et al. Diffusion weighted imaging of normal and malignant prostate tissue at 3.0T.J Magn Reson Imaging,2006,23:130-134.
  • 7Nakashima J,Tanimoto A,Imai Y,et al. Endorectal MRI for prediction of tumor site,tumor size,and local extension of prostate cancer.Urology,2004,64:101-105.
  • 8Miao H,Fukatsu H,Ishigaki T.Prostate cancer deteetion with 3-T MRI:comparison of diffusion weighted and T2-weighted imaging.Eur Radiol,2007,61:297-302.
  • 9Kurhanewicz J,Vigneron DB,Hricak H,et al.Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24Y0.7-cm3) spatial resolution.Radiology,1996,198:795-805.
  • 10Liu X,Zhou L,Peng W,et al.Effect of intravenous gadoliniumDTPA on diffusion-weighted imaging for prostate lesions and normal tissue at 3.0-Tesla magnetic resonance imaging.Radiology,2011,259:903-910.

共引文献37

同被引文献135

  • 1彭涛,伍兵,肖建明.磁共振波谱与扩散加权成像技术诊断前列腺癌的比较研究[J].四川大学学报(医学版),2013,44(5):827-831. 被引量:6
  • 2王霄英,周良平,丁建平,王刚,肖江喜,蒋学祥.中国正常成年男性前列腺的MRS定量分析[J].中国医学影像技术,2003,19(5):576-578. 被引量:24
  • 3周良平,王霄英,李飞宇,丁建平,蒋学祥.正常中国成年男性前列腺MRS的研究:解剖区域和年龄的影响[J].实用放射学杂志,2005,21(7):731-735. 被引量:20
  • 4苏鸿学,刘明,王建业,魏东.前列腺增生合并慢性前列腺炎临床分析[J].中华老年医学杂志,2007,26(9):664-666. 被引量:2
  • 5Fan L, Sher A, Kohan A, et al. PET/MRI in Lung Cancer[J].Semin Roentgenol, 2014, 49(4): 291-303.
  • 6Mcneal J E, Redwine E A, Freiha F S, Stamey T A. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread[J]. Am J Surg Pathol, 1988, 12:897-906.
  • 7Shannon B A, Mcneal J E, Cohen R J. Transition zone carcinoma of the prostate gland: a common indolent tumour type that occasionally manifests aggressive behaviour[J]. Pathology, 2003, 35:467-471.
  • 8Ahmed H U, Freeman A, Kirkham A, Sahu M, Scott R, Allen C, et al. Focal therapy for localized prostate cancer: a phase Ⅰ/Ⅱ trial[J]. J Urol, 2011, 185:1246-1254.
  • 9Oto A, Kayhan A, Jiang Y, Tretiakova M, Yang C, Antic T, et al. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging[J]. Radiology, 2010, 257:715-723.
  • 10Barentsz J O, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G, et al. ESUR prostate MR guidelines 2012[J]. Eur Radiol, 2012, 22:746-757.

引证文献16

二级引证文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部